These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6301276)
1. Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis. Lawrence EC; Teague RB; Gottlieb MS; Jhingran SG; Lieberman J Am J Med; 1983 May; 74(5):747-56. PubMed ID: 6301276 [TBL] [Abstract][Full Text] [Related]
2. Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management? Turner-Warwick M; McAllister W; Lawrence R; Britten A; Haslam PL Thorax; 1986 Dec; 41(12):903-13. PubMed ID: 3035736 [TBL] [Abstract][Full Text] [Related]
3. Correlative analysis of longitudinal changes in bronchoalveolar lavage, 67gallium scanning, serum angiotensin-converting enzyme activity, chest X-ray, and pulmonary function tests in pulmonary sarcoidosis. Okada M; Takahashi H; Nukiwa T; Matsuoka R; Furuse M; Kitamura S; Kira S Jpn J Med; 1987 Aug; 26(3):360-7. PubMed ID: 2826860 [TBL] [Abstract][Full Text] [Related]
4. Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Predicting response to therapy. Baughman RP; Fernandez M; Bosken CH; Mantil J; Hurtubise P Am Rev Respir Dis; 1984 May; 129(5):676-81. PubMed ID: 6326626 [TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar lavage, serum angiotensin-converting enzyme, and gallium-67 scanning in extrathoracic sarcoidosis. Wallaert B; Ramon P; Fournier E; Tonnel AB; Voisin C Chest; 1982 Nov; 82(5):553-5. PubMed ID: 6290142 [TBL] [Abstract][Full Text] [Related]
6. Effects of oral steroids on immunoglobulins in bronchoalveolar lavage fluid in active sarcoidosis. Spatafora M; Mirabella A; Rossi GA; Bonanno A; Riccobono L; Merendino A; Bellia V; Bonsignore G Eur Respir J; 1988 Jun; 1(6):505-9. PubMed ID: 3262533 [TBL] [Abstract][Full Text] [Related]
7. Procollagen III peptide in bronchoalveolar lavage fluid. A potential marker of altered collagen synthesis reflecting pulmonary disease in sarcoidosis. Bjermer L; Thunell M; Hällgren R Lab Invest; 1986 Dec; 55(6):654-6. PubMed ID: 3023750 [TBL] [Abstract][Full Text] [Related]
8. Prediction of therapeutic response in steroid-treated pulmonary sarcoidosis. Evaluation of clinical parameters, bronchoalveolar lavage, gallium-67 lung scanning, and serum angiotensin-converting enzyme levels. Hollinger WM; Staton GW; Fajman WA; Gilman MJ; Pine JR; Check IJ Am Rev Respir Dis; 1985 Jul; 132(1):65-9. PubMed ID: 2990271 [TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical parameters, bronchoalveolar lavage, gallium-67 lung uptake, and serum angiotensin converting enzyme in assessing the activity of sarcoidosis. Staton GW; Gilman MJ; Pine JR; Fajman WA; Check IJ Sarcoidosis; 1986 Mar; 3(1):10-8. PubMed ID: 3033784 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Hällgren R; Eklund A; Engström-Laurent A; Schmekel B Br Med J (Clin Res Ed); 1985 Jun; 290(6484):1778-81. PubMed ID: 3924250 [TBL] [Abstract][Full Text] [Related]
11. Long-term therapy with deflazacort in chronic sarcoidosis. Rizzato G; Fraioli P; Montemurro L Chest; 1991 Feb; 99(2):301-9. PubMed ID: 1846572 [TBL] [Abstract][Full Text] [Related]
12. Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosis. Prior C; Barbee RA; Evans PM; Townsend PJ; Primett ZS; Fyhrquist F; Grönhagen-Riska C; Haslam PL Eur Respir J; 1990 Nov; 3(10):1146-54. PubMed ID: 1965306 [TBL] [Abstract][Full Text] [Related]
14. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Baughman RP; Lower EE Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1268-71. PubMed ID: 2252243 [TBL] [Abstract][Full Text] [Related]
15. Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis. Lawrence EC; Brousseau KP; Berger MB; Kurman CC; Marcon L; Nelson DL Am Rev Respir Dis; 1988 Apr; 137(4):759-64. PubMed ID: 3128148 [TBL] [Abstract][Full Text] [Related]
16. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis. Alberts C; van der Mark TW; Jansen HM Eur Respir J; 1995 May; 8(5):682-8. PubMed ID: 7656936 [TBL] [Abstract][Full Text] [Related]
17. [Increased concentration of angiotensin I converting enzyme in the alveolar fluid of patients with sarcoidosis]. Baumann FC; Stanislas-Leguern GM; Mordelet-Dambrine MS; Huchon GJ; Marsac JH; Andreux JP; Chrétien J Biomedicine; 1981 Oct; 35(5):170-1. PubMed ID: 6274441 [TBL] [Abstract][Full Text] [Related]
18. [Determination of the activity and control of the course of sarcoidosis using bronchoalveolar lavage]. Bauer W; Simona R; Morell A; Baumann HR Schweiz Med Wochenschr; 1984 Jun; 114(25):920-4. PubMed ID: 6235580 [TBL] [Abstract][Full Text] [Related]
19. Lung inflammation in sarcoidosis: comparison of serum angiotensin-converting enzyme levels with bronchoalveolar lavage and gallium-67 scanning assessment of the T lymphocyte alveolitis. Schoenberger CI; Line BR; Keogh BA; Hunninghake GW; Crystal RG Thorax; 1982 Jan; 37(1):19-25. PubMed ID: 6280331 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme in bronchoalveolar lavage fluid in sarcoidosis. Allen RK; Pierce RJ; Barter CE Sarcoidosis; 1992 Mar; 9(1):54-9. PubMed ID: 1344045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]